Correlating EGFR Expression with Receptor-Binding Properties and Internalization of <sup>64</sup>Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines - Concepedia

Concepedia

Publication | Open Access

Correlating EGFR Expression with Receptor-Binding Properties and Internalization of <sup>64</sup>Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines

DOI Full Paper Access

83

Citations

17

References

2008

Year

Martin Eiblmaier, Laura Meyer, Mark A. Watson, Paula M. Fracasso, Linda J. Pike, Carolyn J. Anderson

Journal of Nuclear Medicine

Abstract

(64)Cu-DOTA-cetuximab was successfully used to detect and quantify EGFR expression in cervical cancer tumors, and small-animal PET/CT of EGFR-expressing CaSki tumors suggests potential for PET/CT of EGFR-positive tumors.

References

	Year	Citations
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry Ki Y. Chung, Jinru Shia, Nancy E. Kemeny, Journal of Clinical Oncology	2005	1.1K
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study Mauro Moroni, Silvio Veronese, Silvia Benvenuti, The Lancet Oncology Cancer EpidemiologyMedicinePathologyColorectal CancerCancer Genomics	2005	948
Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Neil I. Goldstein, Marie Prewett, Kazys Zuklys, PubMed ImmunologyBiological EfficacyCell GrowthImmunotherapyTumor Biology	1995	791
Efficient production of high specific activity 64Cu using a biomedical cyclotron Deborah W. McCarthy, R. E. Shefer, R. E. Klinkowstein, Nuclear Medicine and Biology EngineeringBiochemistryBiomedical CyclotronNatural SciencesBiotechnology	1997	524
Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. A.-M. F. Kersemaekers, G. J. Fleuren, Gemma G. Kenter, PubMed PathologyGynecologyUterine CervixCancer BiologyTumor Biology	1999	246
Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody Weibo Cai, Kai Chen, Lina He, European Journal of Nuclear Medicine and Molecular Imaging Knockout MouseTumor BiologyRadiation OncologyEgfr ExpressionPathology	2007	240
Molecular Determinants of Cetuximab Efficacy Daniel Vallböhmer, Wu Zhang, Michael A. Gordon, Journal of Clinical Oncology	2005	234
An Assessment of the Effects of Shell Cross-Linked Nanoparticle Size, Core Composition, and Surface PEGylation on in Vivo Biodistribution Xiankai Sun, Raffaella Rossin, Jeffrey L. Turner, Biomacromolecules	2005	222
Receptor-Binding, Biodistribution, and Metabolism Studies of <sup>64</sup> Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive Tumors Wen Ping Li, Laura Meyer, David A. Capretto, Cancer Biotherapy and Radiopharmaceuticals	2008	113
Synchronous Coexpression of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in Carcinomas of the Uterine Cervix Gwi Eon Kim, Yong Bae Kim, Nam Hoon Cho, Clinical Cancer Research	2004	106

Page 1